Literature DB >> 782370

T and B lymphocytes in contact and atopic dermatitis.

F J Carapeto, R K Winkelmann, R E Jordon.   

Abstract

The pattern of distribution of T and B lymphocytes was investigated in a group of patients with contact, atopic, and mixed dermatitis by means of immunofluorescence and T-cell rosette tests. A significant increase (P less than .001) in B lymphocytes with surface IgD but without changes in the lymphocytes bearing other immunoglobulins or C3 and T cells was noted in patients with contact dermatitis when compared with a control group. A significant increase (P less than .001) in B lymphocytes carrying IgE and a significant decrease (P less than .001) in the total numbers of T cells were noted in patients with atopic dermatitis, and a significant increase in B lymphocytes positive for IgD (P less than .001) and IgE (P less than .003) with a decrease in the number of lymphocytes bearing IgG were the most important changes observed in patients with mixed contact and atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782370

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  T-cell function in atopic dermatitis. Controlled examination of concanavalin A dose-response relations in cultured lymphocytes.

Authors:  E Schöpf; A Kapp; C W Kim
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

2.  Herpes simplex infections in atopic eczema.

Authors:  B J Liddle
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

3.  Increase of lymphocytes with Fc receptors for IgE in patients with allergic rhinitis during the grass pollen season.

Authors:  H L Spiegelberg; R A Simon
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

4.  Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis.

Authors:  Elizabeth Yan Zhang; Aaron Yun Chen; Bao Ting Zhu
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.